Google Bets $40 Billion on Anthropic’s Survival

article image
On April 24, 2026, Google committed up to $40 billion to Anthropic (a San Francisco-based AI startup competing directly with OpenAI), with $10 billion deployed immediately at a $350 billion valuation and another $30 billion contingent on performance milestones. This is the largest single corporate bet on a foundation model builder to date — and it comes from a company already fielding its own Gemini models. The deal reveals Google’s dual strategy: compete at the model layer while also supplying the infrastructure that keeps rivals alive. Anthropic relies heavily on Google Cloud for tensor processing units (TPUs), specialized chips designed for AI workloads and among the few credible alternatives to Nvidia’s processors. The new investment expands an earlier arrangement announced in April, under which Anthropic partnered with Google and chipmaker Broadcom to access 3.5 gigawatts of TPU-based capacity starting in 2027. Google Cloud will now provide an additional 5 gigawatts over the next five years, with room to scale further. The fresh capital follows widespread complaints about Claude usage limits in recent weeks and a flurry of infrastructure deals — including a data center agreement with CoreWeave and a separate $5 billion investment from Amazon, part of a broader commitment expected to reach $100 billion for around 5 gigawatts of compute over time. Anthropic released its latest model, Mythos, to a limited group of partners earlier this month. The company describes Mythos as its most powerful model to date, with significant cybersecurity applications. Due to potential misuse, Anthropic has restricted broader access while working with select organizations to evaluate risks — though the model has already fallen into unsanctioned hands. It is also likely expensive to run at scale. The AI race is increasingly defined by access to compute needed to train and deploy these systems. OpenAI has moved aggressively to secure capacity through multi-hundred-billion-dollar deals across cloud providers, chip suppliers, and energy infrastructure, including an expanded agreement with chipmaker Cerebras this month. The Google investment is expected to value the search giant at $800 billion or more. The company is also reportedly considering an IPO as soon as October.

FCC Adds Portable Hotspots to Foreign Router Ban

On April 23, 2026, the Federal Communications Commission (US telecom regulator) clarified that its ban on foreign-made consumer routers also covers portable hotspot devices. The agency added a new section to its FAQ stating that consumer-grade portable or mobile MiFi Wi-Fi or hotspot devices for residential use fall under the ban. Mobile phones with hotspot features remain exempt. The ban stems from a President Trump directive on reducing the use of foreign technology for national security reasons. The FCC will not approve new device models made at least partly outside the US unless the Department of Defense or Department of Homeland Security determines the device poses no national security risk. Virtually every router maker will need an exemption for future products, given that components inside routers are made in countries including Taiwan, South Korea, Japan, and China. Netgear became the first major vendor to obtain an exemption last week. Amazon-owned Eero received approval this week. The FCC defines routers broadly as consumer-grade networking devices primarily intended for residential use that can be installed by the customer and forward data packets between networked systems. The ban does not cover industrial, enterprise, or military equipment, nor does it affect analog telephone adapters with Ethernet LAN and WAN ports, femtocells, or optical network terminals.

Army Sergeant Arrested for Polymarket Bets on Maduro Capture

On April 24, 2026, US Army Master Sergeant Gannon Ken Van Dyke was arrested for insider trading after allegedly making prediction-market wagers on the timing of the military’s capture of Venezuelan President Nicolás Maduro. Van Dyke profited nearly $410,000 by placing bets on Polymarket, according to the Department of Justice. He was indicted on charges of unlawful use of confidential government information for personal gain, theft of nonpublic government information, commodities fraud, wire fraud, and making an unlawful monetary transaction. Van Dyke, a 38-year-old North Carolina resident stationed at Fort Bragg in Fayetteville, has been on active duty since 2008 and with US Army Special Forces since 2023. He was bound by nondisclosure agreements forbidding him from revealing classified or sensitive military information. Van Dyke allegedly started making bets about a week before the January 3 capture of Maduro, placing approximately 13 wagers totaling $33,034 from December 27, 2025, through the evening of January 26 — all taking the yes position on outcomes including US forces in Venezuela by January 31, 2026, and Maduro out by January 31, 2026. He later sent most of his proceeds to a foreign cryptocurrency vault before depositing them into a newly created online brokerage account and took steps to conceal his identity as the trader in the Maduro- and Venezuela-related markets. President Trump compared the wagers to Pete Rose betting on his own team, saying he would look into it. Polymarket said it identified a user trading on classified government information, referred the matter to the DOJ, and cooperated with the investigation. The Commodity Futures Trading Commission separately filed a civil complaint seeking restitution, disgorgement, civil monetary penalties, trading and registration bans, and a permanent injunction.

Europe Approves Moderna Flu-COVID Combo — US Still Waits

On April 21, 2026, the European Commission authorized Moderna to market mCOMBRIAX, an mRNA-based combination vaccine against both flu and COVID-19, making it the world’s first authorized combination shot for the two respiratory viruses. The decision follows a positive review in February from the European Medicines Agency’s key committee. Moderna CEO Stéphane Bancel said the vaccine aims to simplify immunization for adults, particularly those at high risk, and offers an important new option for Europeans while strengthening the resilience of healthcare systems across Europe. mCOMBRIAX combines Moderna’s COVID-19 vaccine with an investigational influenza vaccine called mRNA-1010, which is still under review in Europe. The combination shot was authorized based on findings from a Phase III clinical trial of around 4,000 adults. In both age groups — 50 to 64 and 65 and up — mCOMBRIAX spurred statistically-significant higher immune responses against common flu strains and against SARS-CoV-2 than comparator vaccines. There were no concerns over safety or adverse events. Availability is not yet on the horizon for the US. Since the second Trump administration took office last year and Health Secretary Robert F. Kennedy Jr. began implementing his anti-vaccine and anti-mRNA agenda, Moderna has faced significant obstacles. Under Kennedy, the government has canceled hundreds of millions of dollars in grants to Moderna that would have supported mRNA vaccine development. Moderna withdrew its FDA application for mCOMBRIAX in May 2025, saying it would resubmit after collecting more data on mRNA-1010. The company has not yet resubmitted. In February 2026, the FDA refused to review Moderna’s application for mRNA-1010 — a decision made by political appointee Vinay Prasad over objections by FDA staff. A week later, the agency reversed the decision. The FDA is now expected to issue a decision on the flu vaccine by August 5. Prasad is set to exit the agency at the end of this month.

The sharpest signal today is not that Google is placing a $40 billion bet on a rival — it is that the infrastructure layer now dictates who survives in AI. Anthropic’s need for 8.5 gigawatts of compute capacity, spread across Google, Amazon, and CoreWeave, shows that model differentiation means nothing without access to chips and power. OpenAI recognized this early and locked in multi-hundred-billion-dollar deals. Anthropic is now racing to catch up. Meanwhile, the US continues to export regulatory chaos — banning foreign-made routers while allowing a soldier to bet on classified military operations on a platform backed by the president’s son. Europe is approving Moderna’s flu-COVID combo shot while the FDA stalls under political pressure. If you are tracking where capital flows next, watch who controls the compute. The rest is commentary.

If this was useful, drop a like or comment below. More signal, less noise — every time.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *